Wesley “Wes” Yin is a Professor of Economics at the UCLA Luskin School of Public Affairs, and the Anderson School of Management. He is also a Research Associate at the National Bureau of Economic Research, and a Faculty Affiliate at the Jameel Poverty Action Lab at MIT. He is currently on leave during the 2023-2024 year, serving as Chief Economist of the White House Office of Management and Budget.

Yin’s research focuses on health care, consumer finance, and economic inequality. His recent work studies competition and market power in health care, and the links between health care financing and consumer financial health and well-being.

His work has been published in leading economics and policy outlets such as the Quarterly Journal of Economics, the American Economic Review, the Review of Economics and Statistics, JAMA, Health Affairs, and the Hamilton Project at the Brookings Institution, and has been covered by the New York Times, Washington Post, New Yorker, Forbes, The Guardian, Bloomberg, The Atlantic, Vox, and others.

From 2012 to 2014, Yin served in the Obama Administration as Acting Chief Economist and Deputy Assistant Secretary for Microeconomic Policy at the U.S. Department of the Treasury, and in the White House Council of Economic Advisers, advancing policing on health care quality, insurance affordability, higher education finance, and housing market stability. Since 2014, Yin has advised the state of California on health care reforms, including the design of state subsidies for marketplace insurance.

Previously, he was an assistant professor at the University of Chicago and Boston University, and a Robert Wood Johnson Scholar in Health Policy at Harvard University. He received his PhD in economics from Princeton University.

Working Papers

The Effects of Medical Debt Relief: Evidence from Two Randomized Experiments (with Ray Kluender, Neale Mahoney and Francis Wong). NBER Working Paper #32315, April 2024. Revise and resubmit at The Quarterly Journal of Economics.

Pre-registrations: J-PAL Summary. AEA Pre-registration 1 (Collector Debt). AEA Pre-registration 2 (Hospital Debt).  Media coverage: New York Times, The Guardian, Forbes, St. Louis Public Radio, Bloomberg, Vox, The Atlantic, Vox Today, Explained (Podcast), Tradeoffs (Podcast)

Provider Market Power and Adverse Selection in Health Insurance Markets (with Nicholas Tilipman). Draft available, upon request.

 

Selected Publications  

The Impact of Financial Assistance Programs on Health Care Utilization (with Alyce Adams, Ray Kluender, Neale Mahoney, Jinglin Wang, and Francis Wong). American Economic Review: Insights. 4(3), September 2022: 389-407. Online Appendix.

Personalized Telephone Outreach Increased Health Insurance Take-Up for Hard-to Reach Populations (w/ Rebecca Myerson, Nicholas Tilipman, Andrew Fehrer, Honglin Li, and Isaac Menashe) Health Affairs. 41(1): 129–137, January 2022.

Trends in Medical Debt During the COVID Pandemic (with Raymond Kluender, Benedict Guttman-Kenney, Neale Mahoney, Francis Wong, and Xuyang Xia) JAMA Health Forum 3(5):e221031, May 2022.

Medical Debt in the United States, 2009-2020 (with Ray Kluender, Neale Mahoney and Francis Wong) Journal of the American Medical Association 326(3), July 2021. Media Coverage: NY Times, Washington Post, Vox, Marketwatch, CBS Evening News, Marketplace. JAMA editorial.

The Role of Behavioral Frictions in Health Insurance Marketplace Enrollment and Risk: Evidence from a Field Experiment. (with Richard Domurat and Isaac Menashe) American Economic Review 111(5): 1549–1574 , May 2021. [Online Appendix] Media Coverage: Tradeoffs Podcast

The Market for High-Quality Medicine: Retail Chain Entry and Drug Quality in India. 2019. (with Daniel Bennett) Review of Economics and Statistics 101(1) p.76-90 [Appendix]

Insurers’ Negotiating Leverage and the External Effect of Medicare Part D. 2015. (with Darius Lakdawalla), Review of Economics and Statistics 97:2 p.314-331 (an earlier version appears as NBER working paper no. 16251). Media coverage: New Yorker

Value of Survival Gains in Chronic Myeloid Leukemia (with John Penrod, J. Ross Maclean, Darius Lakdawalla and Tomas Philipson) American Journal of Managed Care 2012 Nov;18(11 Suppl):S257-64

R&D Policy, Agency Costs and Innovation in Personalized Medicine. 2009. Journal of Health Economics 28(5): 950-962.

Market Incentives and Pharmaceutical Innovation. 2008. Journal of Health Economics 27(4):1060-1077.

Female Empowerment: Impact of a Commitment Savings Product in the Philippines. 2010. (with Nava Ashraf and Dean Karlan) World Development 38(3): 333-344.

The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures (with Anirban Basu, James Zhang, Atonu Rabbani, David Meltzer, and Caleb Alexander) Lead article at Annals of Internal Medicine 148(3): 169-177. Annals’ Summary for Patients.

Designing Targeting Schemes with Poverty Maps: Does Disaggregation Help?. 2007. (with Berk Özler, Chris Elbers, Tomoki Fujii, Peter Lanjouw) Journal of Development Economics 83(1).

Tying Odysseus to the Mast: Evidence from a Commitment Savings Product in the Philippines. 2006. (with Nava Ashraf and Dean Karlan) Quarterly Journal of Economics 121(2). Winner of TIAA-CREF 2006 Certificate of Excellence.

Deposit Collectors (with Nava Ashraf and Dean Karlan). 2006. Advances in Economic Analysis & Policy 6(2), Article 5.

 

Other Publications and Policy Articles  

Options To Improve Affordability In California’s Individual Health Insurance Market, (with Peter Lee, Katie Ravel and Nicholas Tilipman), a Covered California report for Gov. Newsom, California State Senate and State Assembly pursuant to AB1810, February, 2019

How retail drug markets in poor countries develop (with Dan Bennett) VoxDev.org, August, 13^th, 2018.

Potential Impacts of Graham-Cassidy-Heller-Johnson on Californians and the Individual Health Insurance Market (with John Bertko) Covered California Report, September 25, 2017

Evaluating the Potential Consequences of Terminating Direct Federal Cost-Sharing Reduction (CSR) Funding (with Richard Domurat) Covered California Report, January 26, 2017  [Appendix]

Trump’s “populist” economic proposals come with massive catches. Here’s what to watch for. Vox, November 18, 2016

Strengthening Risk Protection through Private Long-Term Care Insurance. Brookings Institution, Hamilton Project Discussion Paper 2015-06, June 2015. Policy Brief.

The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries’ Prescription Utilization and Expenditures (with Caleb Alexander and Anirban Basu), Health Services Research, February 2010, 45(1), pp. 133-151   

Valuing health technologies at NICE: Recommendations for Improved Incorporation of Treatment Value in HTA (with Dana Goldman, Darius Lakdawalla and Tomas Philipson) Health Economics October 2010, 10(11) pp. 1109-1116

Solutions and Challenges to Curing Global Health Inequality Innovations 2(4), October 2007, 2(4), pp. 72-80

Testing Savings Product Innovations Using an Experimental Methodology (with Nava Ashraf and Dean Karlan), Asian Development Bank, Economics and Research Department Technical Paper No. 8. November, 2003

A Review of Commitment Savings Products in Developing Countries (with Nava Ashraf, Nathalie Gons, Dean Karlan) ERD Working Paper, July 2003.

 

Teaching

Public Finance and the Economics of Inequality (Econ 415)

Health Care Finance and Management (MBA and MPP elective) (MGMT298 & PP290)

Econometrics for Policy Analysis (MPP Core) (PP208)

Applied Policy Project (APP) Capstone Advisor (PP298A-D)